What goes up must come down, and there are a lot of stocks that look vulnerable to a plunge right now. With the market at an all-time high, many stocks have seen their share price double or even triple in the last 12 months. Yet more than a few of these high-fliers look as if
Stocks to sell
As the stock market navigates through 2024, certain stocks are showing signs that they might not be the best holdings for your portfolio. Here are three “ticking time bombs” that investors might consider as stocks to sell, to preserve capital and improve one’s overall risk-adjusted returns. Some stocks on this list have high valuations that
In an era where stock prices often reach dizzying heights driven by optimism and investor enthusiasm, the risk of market bubbles remains ever-present. While soaring stock valuations can tempt investors with the promise of substantial returns, they frequently become unsustainable, leading to significant corrections. Recognizing when a stock is overpriced and poised for a potential
Investing in the stock market can be a highly rewarding pursuit. However, it also brings an oasis of risks. Some stocks possess significant financial and operational weaknesses that may lead to declines in their value. Here, the focus is on three such stocks considered for the list of stocks to sell. Each of these companies is a
Artificial Intelligence, or AI, has been the hottest sector in the stock market. Since OpenAI released ChatGPT in November 2022, it has been a race to develop the best and smartest generative AI platforms. Bloomberg Intelligence issued a report that potentially valued the generative AI industry at $1.3 trillion by 2032. The AI hardware sector has
Last week I warned about the energy use of Nvidia (NASDAQ:NVDA) AI chips. The stock shrugged it off. Shares that sold for $118 as recently as June 24 are trading at $134 per share today. The worries are not being reflected in the stock price because they’re not yet hitting sales. Nvidia dominates the data
Rivian Automotive (NASDAQ:RIVN) is in the middle of a tremendous run higher. A partnership with Volkswagen (OTCMKTS:VWAGY) will infuse billions into the electric vehicle automaker and give it an ownership stake in the company. The EV industry itself is showing life, with many automakers reporting robust deliveries for the second quarter. Many are reading this
It’s crucial to steer clear of potential pitfalls that could sink your portfolio. With the S&P 500 and Nasdaq posting impressive year-to-date gains, it’s tempting to get caught up in the bullish fervor. However, beneath the surface, there are warning signs that shouldn’t be ignored. In the near-term, the market’s resilience in the face of
Amid multiple signs of a macroeconomic slowdown in the U.S. and increased competition in the advertising space, I advise investors to sell Meta Platforms (NASDAQ:META) stock. Also importantly, there is no indication that the company has a “killer” AI app. As a result, the Street does not seem very enamored with the company at this
The current state of the U.S. economy is somewhat optimistic yet still filled with uncertainties and risks, making it an excellent moment to uncover overvalued stocks to sell. On one hand, cautious optimism is supported by the Federal Reserve’s projected rate cut, which might lead to more accommodating financial conditions later in the year. However,
Government incentives and shifts in consumer preferences have guided the momentous rise in NIO (NYSE:NIO) stock over the past several years. Nio’s revenue exceeded $7.8 billion for FY2023, but it’s losing its spark. A beleaguered economy in China coupled with intense competition have made it hard for the smaller EV maker to not just grow
Since I wrote about Amazon’s (NASDAQ:AMZN) $190 breakout, the stock has failed to breach the $200 territory. My original thesis cited the “Prime Day” effect where Amazon stock historically did well because of Prime Day (happening in mid-july this year), not to mention that July has traditionally been a good month for the markets. In addition,
The S&P 500 is up more than 50% from 2022 lows. The primary reason for the resilience of the stock market is enthusiasm around AI stocks. Excitement surrounding artificial intelligence and its potential as a revolutionary technology have sent AI shares skyward, creating what many believe is a bubble reminiscent of the dotcom bubble at the
Social media has taken the market by surprise. With Meta Platforms (NASDAQ:META) leading the way but joined by Alphabet (NASDAQ:GOOG, GOOGL), and Snap (NASDAQ:SNAP), the social media industry is expected to grow at a compound annual growth rate (CAGR) of nearly 26% through 2031. Despite this, some companies are falling behind on capitalizing on this
Meme stocks to sell continue sounding the alarm bells this year. However, this year’s explosiveness in meme stocks is notably subdued compared to the original retail trading frenzy. Hence, the stock market seems to have evolved, and smart money is now approaching these stocks with greater caution and strategy. Moreover, according to Vanda Research, inflows
Whether or not you’re bullish on artificial intelligence (AI), it’s had an undeniable impact upon marketing and branding strategies of renowned tech companies. AI is forcing tech into the machine learning (ML) era. Yet, not every tech company is truly a contributor to the AI revolution. These companies result in overvalued AI stocks and can
Last month, Nikola (NASDAQ:NKLA) shares cratered in price, following the announcement and completion of a 1-for-30 reverse stock split. However, so far this month, Nikola stock has been bolting out of the stock market junkyard. Since July 2, this fallen angel of an EV stock has bounced back from its lows, and has climbed back
AI chip stocks have been zooming higher in recent days. Intel (NASDAQ:INTC) shares are no exception. Yet while a quick move back to the mid-$30s per share for Intel stock may look like a sign to buy before it’s too late, consider the following before putting in a “buy” order. The market may keep bidding
Biotechnology stocks can be thrilling and profitable when you’re on the winning side of a trade. G1 Therapeutics’ (NASDAQ:GTHX) started hot, but then the bottom fell out after an unfortunate announcement. With that in mind, G1 Therapeutics stock is just too risky to recommend right now. Based in North Carolina, G1 Therapeutics specializes in oncology
There’s definitely a science to picking beaten-down gems in the stock market. If you get it wrong, you could lose a lot of money. Ginkgo Bioworks (NYSE:DNA) is certainly an interesting company and Ginkgo Bioworks stock is beaten down, but the risk-to-reward profile just isn’t favorable right now. Ginkgo Bioworks, which specializes in cell programming
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 155
- Next Page »